Learning Objectives
- Review the clinical presentation of ADHD in adults
- Review how to best diagnose ADHD and challenges in making the diagnosis
- Review treatment options for adults with ADHD
Jeffrey Newcorn, MD
Dr. Newcorn is professor of psychiatry and pediatrics, director of the Division of ADHD and Learning Disorders at Icahn School of Medicine at Mount Sinai, and director of Pediatric Psychopharmacology for the Mount Sinai Health System. He is also president of APSARD (American Professional Society of ADHD and Related Disorders). Dr. Newcorn is a highly regarded clinician - researcher with special expertise in the areas of ADHD, aggression, descriptive psychopathology of child and adolescent disorders, and child and adolescent psychopharmacology, whose academic work spans both clinical and translational topics. Over the course of his career, he has published over 350 articles and book chapters on these and related subjects. His most recent research focuses on the clinical and neurobiological basis of differential response to ADHD treatments, utilizing data obtained from clinical, pharmacogenetic and fMRI measures, as well as the neurobiological basis of substance abuse risk in individuals with ADHD. In addition, he has studied or helped to develop many of the emerging drugs in the ADHD field. Dr. Newcorn has received numerous awards for his work, including the Hulse Award for lifetime achievement from the New York Council on Child and Adolescent Psychiatry (2002), and the Elaine Schlosser Lewis Award for Research in Attention Deficit Disorder (2018). He was elected to the CHADD Hall of Fame in 2014.
- Back to the schedule